Skip to main content

Table 3 Description of study variables in patients with co-occurrence of HCC and CE (HCC + CE) as well as control patients with HCC (HCC)

From: Co-existence of hepatocellular carcinoma and cystic echinococcosis

Condition

Variable

HCC + CE (n = 13) No. (%)

HCC (n = 65) No. (%)

aP

Gender

Male

8 (61.54)

40 (61.54)

1.00

Female

5 (38.46)

25 (61.54)

 

Virus infection

No

6 (46.15)

31 (47.69)

0.7769

Hepatitis A, B and C virus

Yes

7 (53.85)

34 (52.31)

 

Alcohol consumption

No

13 (100)

63 (96.92)

0.0810

*Yes

0 (0)

2 (3.08)

 

Aflatoxin

No

13 (100)

65 (100)

1.00

Yes

0 (0)

0 (0)

 

NASH

No

13 (100)

63 (96.92)

0.0810

Yes

0 (0)

2 (3.08)

 

Cirrhosis

No

3 (23.08)

17 (26.15)

0.6218

Yes

10 (76.92)

48 (73.85)

 

Hemochromatosis

No

13 (100)

65 (100)

1.00

Yes

0 (0)

0 (0)

 

Family cancer history

No

12 (92.31)

59 (90.77)

0.7998

Yes

1 (7.69)

15 (9.23)

 
  1. * ≥  1 glasses weekly for the past 6 months; NASH nonalcoholic steatohepatitis; aP-Value from χ2 test or Fisher‘s exact test where number is less than 5